Background: Forty adult volunteers were recruited to a study of Salmonella Typhi (S. Typhi) infection in human volunteers. To determine the host response to infection, participants received a S.Typhi challenge dose of 1-5 × 103 or 1-5 × 104 colony forming units (CFU). The antibody secreting cell (ASC) response in infected individuals was studied to characterise the development of immunity following infection.
Background: Staphylococcus aureus is an important cause of blood stream infection. Data from the developing nations about epidemiology, drug resistance, treatment and outcome of S.aureus bacteraemia (SAB) is inadequately represented. Growing rates of SAB coupled with increasing drug resistance has renewed interest in this serious yet common infection.
Methods: A prospective, observational study of all the cases of S. aureus bacteraemia was conducted at a tertiary care hospital in southern India for 1 year. Paired blood culture was done using BacT/ALERT 3D system, antimicrobial susceptibility, clinical data, treatment and outcome was studied.
Results: A total of 70 patients comprising of 13 (19%) children and 57 (81%) adults, 51 (73%) males and 19 (27%) females with S. aureus bacteraemia were studied. The most common source of bacteraemia was skin and soft tissue infection (30%), followed by pneumonia (24%) and bone infection (14%). Among the health care associated SAB, 55% was due to catheter related infections and MRSA constituted for 36% of such infections. As complication of SAB, endocarditis was seen in 4%, and septic manifestation in 31% patients. Most common comorbid condition was diabetes mellitus (40%). Methicillin resistant S. aureus (MRSA) was responsible for 54% of infections, of which 32% were isolated after 48 hrs of hospitalization. Mortality rates for MRSA and Methicillin sensitive S. aureus (MSSA) were 32% and 22% respectively. Multiple drug resistance was observed in 79% of MRSA isolates resistant to 3 or more non-beta lactam antibiotics (ciprofloxacin, amikacin, doxycycline, clindamycin, erythromycin and cotrimoxazole); however, all remained susceptible to linezolid, teicoplanin and vancomycin. Vancomycin was the commonest antibiotic used for treating MRSA infection.
Conclusion: S. aureus is a significant cause of blood stream infections in our setting, with comparable clinical manifestations and mortality with other developed and developing nations. Alarming is the upsurge in MRSA rates. Health care professionals might consider inclusion of anti MRSA drugs in empirical therapy for suspected bacteraemia with identifiable sources and risk factors, pending susceptibility reports. Further, judicious formulation of institutional policies for carrier screening, decontamination, appropriate therapy and infection control practices are the need of the hour in settings with reserved resources.
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